{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:10Z","timestamp":1707524590337},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.7759\/cureus.25557","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:38:10Z","timestamp":1654069090000},"source":"Crossref","is-referenced-by-count":0,"title":["Antituberculous Drug-Induced Hepatitis in a Patient With Congenital Adrenal Hyperplasia: A Clinical Challenge"],"prefix":"10.7759","author":[{"given":"Mudassir","family":"Shafique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Tameez-ud-din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Tameez Ud Din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farooq Mohyud Din","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awais A","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66736-0","article-title":"Congenital adrenal hyperplasia","volume":"365","author":"Merke DP","year":"2005","unstructured":"Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005, 365:2125-36. 10.1016\/S0140-6736(05)66736-0","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz006","article-title":"Increased infection risk in Addison's disease and congenital adrenal hyperplasia","volume":"105","author":"Tresoldi AS","year":"2020","unstructured":"Tresoldi AS, Sumilo D, Perrins M, et al.. Increased infection risk in Addison's disease and congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2020, 105:10.1210\/clinem\/dgz006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","unstructured":"National TB Control Programme - Pakistan. Resource center. (2022). Accessed:  March 15, 2022: http:\/\/ntp.gov.pk\/resource-center\/."},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.26719\/2010.16.Supp.47","article-title":"Tuberculosis control in Pakistan: reviewing a decade of success and challenges","volume":"16","author":"Metzger P","year":"2010","unstructured":"Metzger P, Baloch NA, Kazi GN, Bile KM. Tuberculosis control in Pakistan: reviewing a decade of success and challenges. East Mediterr Health J. 2010, 16:S47-53.","journal-title":"East Mediterr Health J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.93479","article-title":"Mantoux test and its interpretation","volume":"3","author":"Nayak S","year":"2012","unstructured":"Nayak S, Acharjya B. Mantoux test and its interpretation. Indian Dermatol Online J. 2012, 3:2-6. 10.4103\/2229-5178.93479","journal-title":"Indian Dermatol Online J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67862-2","article-title":"Tackling poverty in tuberculosis control","volume":"366","year":"2005","unstructured":"Tackling poverty in tuberculosis control. Lancet. 2005, 366.2063. 10.1016\/S0140-6736(05)67862-2","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.805647","article-title":"Frequently asked questions in patients with adrenal insufficiency in the time of COVID-19","volume":"12","author":"Sabbadin C","year":"2021","unstructured":"Sabbadin C, Betterle C, Scaroni C, Ceccato F. Frequently asked questions in patients with adrenal insufficiency in the time of COVID-19. Front Endocrinol (Lausanne). 2021, 12:805647. 10.3389\/fendo.2021.805647","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4424-8","article-title":"Effectiveness of directly observed treatment short course (DOTS) on treatment of tuberculosis patients in public health facilities of Debre Tabor Town, Ethiopia: retrospective study","volume":"12","author":"Genet C","year":"2019","unstructured":"Genet C, Melese A, Worede A. Effectiveness of directly observed treatment short course (DOTS) on treatment of tuberculosis patients in public health facilities of Debre Tabor Town, Ethiopia: retrospective study. BMC Res Notes. 2019, 12:396. 10.1186\/s13104-019-4424-8","journal-title":"BMC Res Notes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12878-015-0037-1","article-title":"Effect of anti-tuberculosis drugs on hematological profiles of tuberculosis patients attending at University of Gondar Hospital, Northwest Ethiopia","volume":"16","author":"Kassa E","year":"2016","unstructured":"Kassa E, Enawgaw B, Gelaw A, Gelaw B. Effect of anti-tuberculosis drugs on hematological profiles of tuberculosis patients attending at University of Gondar Hospital, Northwest Ethiopia. BMC Hematol. 2016, 16:1. 10.1186\/s12878-015-0037-1","journal-title":"BMC Hematol"},{"key":"ref10","article-title":"Comparison of British Thoracic Society and American Thoracic Society reintroduction guidelines for anti-tuberculous therapy induced liver injury","volume":"64","author":"Zuberi BF","year":"2014","unstructured":"Zuberi BF, Zuberi FF, Bader N, Alvi H, Salahuddin J. Comparison of British Thoracic Society and American Thoracic Society reintroduction guidelines for anti-tuberculous therapy induced liver injury. J Pak Med Assoc. 2014, 64:896-9.","journal-title":"J Pak Med Assoc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen JJ","year":"2006","unstructured":"Saukkonen JJ, Cohn DL, Jasmer RM, et al.. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006, 174:935-52. 10.1164\/rccm.200510-1666ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rppnen.2017.10.009","article-title":"New drugs and perspectives for new anti-tuberculosis regimens","volume":"24","author":"Tiberi S","year":"2018","unstructured":"Tiberi S, Mu\u00f1oz-Torrico M, Duarte R, Dalcolmo M, D'Ambrosio L, Migliori GB. New drugs and perspectives for new anti-tuberculosis regimens. Pulmonology. 2018, 24:86-98. 10.1016\/j.rppnen.2017.10.009","journal-title":"Pulmonology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.36416\/1806-3756\/e20200009","article-title":"Shortened tuberculosis treatment regimens: what is new?","volume":"46","author":"Silva DR","year":"2020","unstructured":"Silva DR, Mello FC, Migliori GB. Shortened tuberculosis treatment regimens: what is new?. J Bras Pneumol. 2020, 46:e20200009. 10.36416\/1806-3756\/e20200009","journal-title":"J Bras Pneumol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/97605-antituberculous-drug-induced-hepatitis-in-a-patient-with-congenital-adrenal-hyperplasia-a-clinical-challenge","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:33Z","timestamp":1707507393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/97605-antituberculous-drug-induced-hepatitis-in-a-patient-with-congenital-adrenal-hyperplasia-a-clinical-challenge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.25557","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}